MIF redox activity

MIF: Most Interesting Factor

Volumn , Issue , 2007, Pages 65-94

  Bernhagen, Jürgen ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84969265037     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812775917_0005     Document Type: Chapter

References (114)

1. David JR. (1966) Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 56: 72-77.
2. George M, Vaughan JH. (1962) Migration of mononuclear cells in capillary tubes. Proc Soc Exp Biol Med 111: 514-521.
3. Weiser WY, Temple DM, Witek-Gianotti JS, et al. (1989) Molecular cloning of cDNA encoding a human macrophage migration inhibtion factor. Proc Natl Acad Sci USA 86: 7522-7526.
4. Bucala R. (1996) MIF rediscovered - cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response. FASEB J 10:1607-1613.
5. Calandra T, Roger T. (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3: 791-800.
6. Morand EF, Leech M, Bernhagen J. (2006) MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov Advance online publication.
7. Mitchell RA. (2004) Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal 16: 13-19.
8. Donnelly SC, Bucala R, Metz CN, et al. (1999) Macrophage migration inhibitory factor and acute lung injury. Chest 116: 111S.
9. Sun H, Bernhagen J, Bucala R, Lolis E. (1996) Crystal structure at 2.6Å resolution of human macrophage migration inhibitory factor. Proc Natl Acad Sci USA 93: 5191-5196.
10. Kato Y, Muto T, Tomura T, et al. (1996) The crystal structure of human glycosylation-inhibiting factor is a trimeric barrel with three 6-stranded β-sheets. Proc Natl Acad Sci USA 93: 3007-3010.
11. Rosengren E, Bucala R, Åman P, et al. (1996) The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol Med 2: 143-149.
12. Kleemann R, Kapurniotu A, Frank RW, et al. (1998) Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as a thiolprotein oxidoreductase. J Mol Biol 280: 85-102.
13. Fernandes AP, Holmgren A. (2004) Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal 6: 63-74.
14. Freedman RB, Klappa P, Ruddock LW. (2002) Protein disulfide isomerases exploit synergy between catalytic and specific binding domains. EMBO Rep 3: 136-140.
15. Holmgren A. (1985) Thioredoxin. Ann Rev Biochem 54: 237-271.
16. Nakamura H. (2005) Thioredoxin and its related molecules: update 2005. Antioxid Redox Signal 7: 823-828.
17. Wood ZA, Schroder E, Robin Harris J, Poole LB. (2003) Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28:32-40.
18. Ellis LBM, Saurugger P, Woodward C. (1992) Identification of the threedimensional thioredoxin motif: related structure in the ORF3 protein of the Staphylococcus aureus mer operon. Biochemistry 31: 4882-4891.
19. Martin JL. (1995) Thioredoxin - a fold for all reasons. Structure 3:245-250.
20. Manevich Y, Fisher AB. (2005) Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radic Biol Med 38: 1422-1432.
21. Siedler F, Rudolph-Böhner S, Doi M, et al. (1993) Redox potentials of active-site bis(cysteinyl) fragments of thiol-protein oxidoreductases. Biochemistry 32: 7488-7495.
22. Ghezzi P. (2005) Oxidoreduction of protein thiols in redox regulation. Biochem Soc Trans 33: 1378-1381.
23. Fratelli M, Goodwin LO, Orom UA, et al. (2005) Gene expression profiling reveals a signaling role of glutathione in redox regulation. Proc Natl Acad Sci USA 102: 13998-14003.
24. Ghezzi P, Bonetto V, Fratelli M. (2005) Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation. Antioxid Redox Signal 7: 964-972.
25. Haendeler J, Tischler V, Hoffmann J, et al. (2004) Low doses of reactive oxygen species protect endothelial cells from apoptosis by increasing thioredoxin-1 expression. FEBS Lett 577: 427-433.
26. Jones DP, Go YM, Anderson CL, et al. (2004) Cysteine/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control. FASEB J 18: 1246-1248.
27. Ghezzi P. (2005) Regulation of protein function by glutathionylation. Free Radic Res 39: 573-580.
28. Haendeler J, Hoffmann J, Tischler V, et al. (2002) Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat Cell Biol 4: 743-749.
29. Andoh T, Chock PB, Chiueh CC. (2002) The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells. J Biol Chem 277: 9655-9660.
30. Baker A, Payne CM, Briehl MM, Powis G. (1997) Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitroand in vivo. Cancer Res 57: 5162-5167.
31. Iwata S, Hori T, Sato N, et al. (1997) Adult T cell leukemia (ATL)-derived factor/human thioredoxin prevents apoptosis of lymphoid cells induced by L-cystine and glutathione depletion: possible involvement of thiol-mediated redox regulation in apoptosis caused by pro-oxidant state. J Immunol 158:3108-3117.
32. Powis G, Mustacich D, Coon A. (2000) The role of the redox protein thioredoxin in cell growth and cancer. Free Radic Biol Med 29: 312-322.
33. Sato N, Iwata S, Nakamura K, et al. (1995) Thiol-mediated redox regulation of apoptosis. Possible roles of cellular thiols other than glutathione in T cell apoptosis. J Immunol 154: 3194-3203.
34. Tagaya Y, Maeda Y, Mitsui A, et al. (1989) ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 8: 757-764.
35. Tanaka T, Hosoi F, Yamaguchi-Iwai Y, et al. (2002) Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J 21: 1695-1703.
36. Nilsson J, Soderberg O, Nilsson K, Rosen A. (2000) Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells. Blood 95: 1420-1426.
37. Kondo N, Ishii Y, Kwon YW, et al. (2004) Redox-sensing release of human thioredoxin from T lymphocytes with negative feedback loops. J Immunol 172: 442-448.
38. Freemerman AJ, Powis G. (2000) A redox-inactive thioredoxin reduces growth and enhances apoptosis in WEHI7.2 cells. Biochem Biophys Res Commun 274: 136-141.
39. Saitoh M, Nishitoh H, Fujii M, et al. (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17:2596-2606.
40. Bishopric NH, Webster KA. (2002) Preventing apoptosis with thioredoxin:ASK me how. Circ Res 90: 1237-1239.
41. Liu Y, Min W. (2002) Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activityindependent manner. Circ Res 90: 1259-1266.
42. Pekkari K, Gurunath R, Arner ES, Holmgren A. (2000) Truncated thioredoxin is a mitogenic cytokine for resting human peripheral blood mononuclear cells and is present in human plasma. J Biol Chem 275: 37474-37480.
43. Pekkari K, Avila-Carino J, Bengtsson A, et al. (2001) Truncated thioredoxin (Trx80) induces production of interleukin-12 and enhances CD14 expression in human monocytes. Blood 97: 3184-3190.
44. Pekkari K, Holmgren A. (2004) Truncated thioredoxin: physiological functions and mechanism. Antioxid Redox Signal 6: 53-61.
45. Smith JA, Pease LG. (1980) Reverse turns in peptides and proteins. CRC Crit Rev Biochem 8: 315-399.
46. Suzuki M, Sugimoto H, Nakagawa A, et al. (1996) Crystal structure of the macrophage migration inibitory factor from rat liver. Nat Struct Biol 3:259-266.
47. Mischke R, Kleemann R, Brunner H, Bernhagen J. (1998) Crosslinking and mutational analysis of the oligomerization state of the cytokine macrophage migration inhibitory factor (MIF). FEBS Lett 427: 85-90.
48. Bernhagen J, Mitchell RA, Calandra T, et al. (1994) Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33: 14144-14155.
49. Calandra T, Bernhagen J, Mitchell RA, Bucala R. (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179: 1985-1902.
50. Thiele M, Bernhagen J. (2005) Link between macrophage migration inhibitory factor (MIF) and cellular redox regulation. Antioxid Redox Signal 7: 1234-1248.
51. Waksman G, Krishna TS, Williams CHJ, Kuriyan J. (1994) Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis. J Mol Biol 236:800-816.
52. Eguchi M, McMillan M, Nguyen C, et al. (2003) Chemogenomics with peptide secondary structure mimetics. Comb Chem High Throughput Screen 6: 611-621.
53. Cabrele C, Flori S, Pegoraro S, Moroder L. (2002) Redox-active cyclic bis(cysteinyl)peptides as catalysts for in vitrooxidative protein folding. Chem Biol 9: 731-740.
54. Shi T, Spain SM, Rabenstein DL. (2004) Unexpectedly fast cis/trans isomerization of Xaa-Pro peptide bonds in disulfide-constrained cyclic peptides. J Am Chem Soc 126: 790-796.
55. Siedler F, Quarzago D, Rudolph-Bohner S, Moroder L. (1994) Redox-active bis-cysteinyl peptides. II. Comparative study on the sequence-dependent tendency for disulfide loop formation. Biopolymers 34: 1563-1572.
56. Zhang R, Snyder GH. (1989) Dependence of formation of small disulfide loops in two-cysteine peptides on the number and types of intervening amino acids. J Biol Chem 264: 18472-18479.
57. Nguyen MT, Beck J, Lue H, et al. (2003) A sixteen residue peptide fragment of macrophage migration inhibitory factor, MIF(50-65), exhibits redox activity and has MIF-like biological functions. J Biol Chem 278:33654-33671.
58. Matsuura T, Sun C, Leng L, et al. (2006) Macrophage migration inhibitory factor increases neuronal delayed rectifier K+ current. J Neurophysiol 95:1042-1048.
59. Sun C, Li H, Leng L, et al. (2004) Macrophage migration inhibitory factor:An intracellular inhibitor of angiotensin II-induced increases in neuronal activity. J Neurosci 24: 9944-9952.
60. Kleemann R, Mischke R, Kapurniotu A, et al. (1998) Specific reduction of insulin disulfides by macrophage migration inhibitory factor (MIF) with glutathione and dihydrolipoamide: potential role in cellular redox processes. FEBS Lett 430: 191-196.
61. Potolicchio I, Santambrogio L, Strominger JL. (2003) Molecular interaction and enzymatic activity of macrophage migration inhibitory factor (MIF) with immunorelevant peptides. J Biol Chem 278: 30889-30895.
62. Lundström-Ljung J, Holmgren A. (1995) Glutaredoxin accelerates glutathione-dependent folding of reduced ribonuclease A together with protein disulfide-isomerase. J Biol Chem 270: 7822-7828.
63. Rouhier N, Gelhaye E, Jacquot JP. (2002) Glutaredoxin-dependent peroxiredoxin from poplar: protein-protein interaction and catalytic mechanism. J Biol Chem 277: 13609-13614.
64. Kleemann R, Kapurniotu A, Mischke R, et al. (1999) Characterization of catalytic center mutants of macrophage migration inhibitory factor (MIF) and comparison with C81S MIF. Eur J Biochem 261: 753-766.
65. Sugimoto H, Taniguchi M, Nakagawa A, et al. (1999) Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 angstrom resolution. Biochemistry 38: 3268-3279.
66. Bast A, Haenen GR. (1988) Interplay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation. Biochim Biophys Acta 963: 558-561.
67. Kagan VE, Shvedova A, Serbinova E, et al. (1992) Dihydrolipoic acid - a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. Biochem Pharmacol 44: 1637-1649.
68. Fukuzawa J, Nishihira J, Hasebe N, et al. (2002) Contribution of macrophage migration inhibitory factor to extracellular signal-regulated kinase activation by oxidative stress in cardiomyocytes. J Biol Chem 277:24889-24895.
69. Sakamoto W, Fujie K, Isomura S, et al. (2002) Secretion of macrophage migration inhibitory factor differs from interleukin-6 in hydrogen peroxideand LPS-stimulated human fibroblasts. Int Immunopharmacol 2: 1123-1131.
70. Takahashi M, Nishihira J, Shimpo M, et al. (2001) Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes. Cardiovasc Res 52: 438-445.
71. Sakamoto W, Nishihira J, Fujie K, et al. (1998) Inhibition of macrophage migration inhibitory factor secretion from macrophages by vitamin E. Biochim Biophys Acta 1404: 427-434.
72. Nguyen M, Lue H, Kleemann R, et al. (2003) The cytokine macrophage migration inhibitory factor (MIF) reduces pro-oxidative stress-induced apoptosis. J Immunol 170: 3337-3347.
73. Jung H, Kim T, Chae HZ, et al. (2001) Regulation of macrophage migration inhibitory factor and thiol-specific antioxidant protein PAG by direct interaction. J Biol Chem 276: 15504-15510.
74. Rhee SG, Chae HZ, Kim K. (2005) Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38: 1543-1552.
75. Immenschuh S, Baumgart-Vogt E. (2005) Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal 7: 768-777.
76. Flohe L, Budde H, Hofmann B. (2003) Peroxiredoxins in antioxidant defense and redox regulation. Biofactors 19: 3-10.
77. Rhee SG, Kang SW, Chang TS, et al. (2001) Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52: 35-41.
78. Rhee SG, Kang SW, Netto LE, et al. (1999) A family of novel peroxidases, peroxiredoxins. Biofactors 10: 207-209.
79. Hofmann B, Hecht HJ, Flohe L. (2002) Peroxiredoxins. Biol Chem 383:347-364.
80. Waeber G, Calandra T, Roduit R, et al. (1997) Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci USA 94: 4782-4787.
81. Lu C, Li Y, Zhao Y, et al. (2002) Intracrine hepatopoietin potentiates AP-1 activity through JAB1 independent of MAPK pathway. FASEB J 16: 90-92.
82. Li Y, Lu C, Xing G, et al. (2004) Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell. Exp Cell Res 300: 379-387.
83. Wang Y, Lu C, Wei H, et al. (2004) Hepatopoietin interacts directly with COP9 signalosome and regulates AP-1 activity. FEBS Lett 572: 85-91.
84. Kleemann R, Hausser A, Geiger G, et al. (2000) Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408: 211-216.
85. Chamovitz DA, Segal D. (2001) JAB1/CSN5 and the COP9 signalosome. A complex situation. EMBO Rep 2: 96-101.
86. Wei N, Deng XW. (2003) The COP9 signalosome. Annu Rev Cell Dev Biol 19: 261-286.
87. Wolf DA, Zhou C, Wee S. (2003) The COP9 signalosome: an assembly and maintenance platform for cullin ubiquitin ligases? Nat Cell Biol 5:1029-1033.
88. Bech-Otschir D, Seeger M, Dubiel W. (2002) The COP9 signalosome: at the interface between signal transduction and ubiquitin-dependent proteolysis. J Cell Sci 115: 467-473.
89. Hwang CY, Ryu YS, Chung MS, et al. (2004) Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1. Oncogene 23: 8868-8875.
90. Chen X, Li Y, Wei K, et al. (2003) The potentiation role of hepatopoietin on activator protein-1 is dependent on its sulfhydryl oxidase activity. J Biol Chem 278: 49022-49030.
91. Eickhoff R, Baldauf C, Koyro HW, et al. (2004) Influence of macrophage migration inhibitory factor (MIF) on the zinc content and redox state of protein-bound sulphydryl groups in rat sperm: indications for a new role of MIF in sperm maturation. Mol Hum Reprod 10: 605-611.
92. Calandra T, Bernhagen J, Metz CN, et al. (1995) MIF as a glucocorticoidinduced modulator of cytokine production. Nature 377: 68-71.
93. Yao K, Shida S, Selvakumaran M, et al. (2005) Macrophage migration inhibitory factor is a determinant of hypoxia-induced apoptosis in colon cancer cell lines. Clin Cancer Res 11: 7264-7272.
94. Le Bras M, Clement MV, Pervaiz S, Brenner C. (2005) Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol Histopathol 20: 205-219.
95. Giles GI, Jacob C. (2002) Reactive sulfur species: an emerging concept in oxidative stress. Biol Chem 383: 375-388.
96. Giles GI, Tasker KM, Jacob C. (2001) Hypothesis: the role of reactive sulfur species in oxidative stress. Free Radic Biol Med 31: 1279-1283.
97. Barzilai A, Yamamoto K. (2004) DNA damage responses to oxidative stress. DNA Repair (Amst) 3: 1109-1115.
98. Zoratti M, Szabo I, De Marchi U. (2005) Mitochondrial permeability transitions:How many doors to the house? Biochim Biophys Acta 1706: 40-52.
99. Zoratti M, Szabo I. (1995) The mitochondrial permeability transition. Biochim Biophys Acta 1241: 139-176.
100. Fingerle-Rowson G, Petrenko O, Metz CN, et al. (2003) The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci USA 100: 9354-9359.
101. Hudson JD, Shoaibi MA, Maestro R, et al. (1999) A proinflammatory cytokine inhibits p53 tumor suppressor activity. J ExpMed 190: 1375-1382.
102. Mitchell RA, Liao H, Chesney J, et al. (2002) Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 99: 345-350.
103. Sakamoto W, Isomura H, Fujie K, et al. (2005) The effect of vitamin K2 on bone metabolism in aged female rats. Osteoporos Int 16: 1604-1610.
104. Kondo N, Ishii Y, Son A, et al. (2004) Cysteine-dependent immune regulation by TRX and MIF/GIF family proteins. Immunol Lett 92: 143-147.
105. Watarai H, Nozawa R, Tokunaga A, et al. (2000) Post-translational modification of the glycosylation inhibiting factor (GIF) gene product generates bioactive GIF. Proc Natl Acad Sci USA 97: 13251-13256.
106. Nickel W. (2003) The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur J Biochem 270:2109-2119.
107. Flieger O, Engling A, Bucala R, et al. (2003) Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter. FEBS Lett 551: 78-86.
108. Burger-Kentischer A, Finkelmeier D, Thiele M, et al. (2005) Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif. FEBS Lett 579: 1693-1701.
109. Pyle ME, Korbonits M, Gueorguiev M, et al. (2003) Macrophage migration inhibitory factor expression is increased in pituitary adenoma cell nuclei. J Endocrinol 176: 103-110.
110. Leng L, Metz CN, Fang YXJ, et al. (2003) MIF signal transduction initiated by binding to CD74. J Exp Med 197: 1467-1476.
111. Meyer-Siegler KL, Leifheit EC, Vera PL. (2004) Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells. BMC Cancer 4: 34.
112. Meyer-Siegler KL, Vera PL. (2005) Substance P induced changes in CD74 and CD44 in the rat bladder. J Urol 173: 615-620.
113. Shen L, Hu J, Lu H, et al. (2003) The apoptosis-associated protein BNIPL interacts with two cell proliferation-related proteins, MIF and GFER. FEBS Lett 540: 86-90.
114. Wadgaonkar R, Dudek SM, Zaiman AL, et al. (2005) Intracellular interaction of myosin light chain kinase with macrophage migration inhibition factor (MIF) in endothelium. J Cell Biochem 95: 849-858.